The combination of the words "dermatology start-up," "collagen" and "University of Southern California licensing agreement" leads somewhat naturally to visions of next-generation plumping injections for aging starlets – but Lotus Tissue Repair Inc., a Cambridge, Mass.-based start-up that today announced both an exclusive licensing deal with USC and a $26 million Series A financing from Third Rock Ventures, has more serious problems in its sights.